GlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
GlaxoSmithKline is recalling Bactroban Cream (Mupirocin Calcium Cream 2%) due to penicillin cross-contamination. The recall covers 7,480 tubes distributed nationwide and in Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for significant injury or adverse health consequences (such as allergic reactions from penicillin contamination) are rated as Severe (4).
Plain-English summary
GlaxoSmithKline, LLC is recalling Bactroban Cream (Mupirocin Calcium Cream 2%), 30 gram tubes, due to penicillin cross-contamination. The affected product is prescription-only and was manufactured in England. The specific lot number is C740906, with an expiration date of February 2017.
The recall involves 7,480 tubes of the product. These units were distributed nationwide and in Puerto Rico. The FDA has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should stop using the affected lot of Bactroban Cream and return it to the pharmacy or point of purchase for a refund or replacement. Patients with a known penicillin allergy should be particularly cautious and consult their healthcare provider regarding alternative treatments.
The recalled product
- Product
- Bactroban Cream, (Mupirocin Calcium Cream 2%), 30 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1527-25,
- Manufacturer
- GlaxoSmithKline, LLC
- Category
- Drug — Topical Antibiotic
- Affected units
- 7,480
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C740906
- Exp. Feb 2017.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by GlaxoSmithKline, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · GlaxoSmithKline, LLC
See all →- ModerateTIVICAY HIV medication carton mislabeled with incorrect expiration date
FDA (Drugs) · 2024-06-12
- ModerateAnoro Ellipta inhalation powder recalled for failed release testing defect
FDA (Drugs) · 2024-01-03
- ModerateDrug Recall: Tivicay Tablets with Incorrect Expiration Date on Label
FDA (Drugs) · 2022-06-01
- HighGlaxoSmithKline Recalls Ventolin HFA Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-05-31
- ModerateGlaxoSmithKline Recalls Ventolin Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-04-12
Same hazard · penicillin contamination
See all →- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereLife Science Pharmacy Recalls TRI-EST Lozenges Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls BI-EST Capsules Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09